FDA agrees to review Moderna’s amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval
Last week, the US Food and Drug Administration (FDA) had said it will not review Moderna’s application for its experiment...
Impressions : 1883
Pfizer CEO expects Covid vaccine approval by October; Favipiravir shows inconclusive results against Covid-19
This week, Phispers brings you updates on vaccines for the novel coronavirus.
While the FDA gave fast track designation to tw...
Impressions : 66902
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.